Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
9.22
-0.24 (-2.54%)
At close: Jun 27, 2025, 4:00 PM
9.39
+0.17 (1.84%)
After-hours: Jun 27, 2025, 7:50 PM EDT
Ocular Therapeutix Employees
Ocular Therapeutix had 274 employees as of December 31, 2024. The number of employees increased by 7 or 2.62% compared to the previous year.
Employees
274
Change (1Y)
7
Growth (1Y)
2.62%
Revenue / Employee
$217,690
Profits / Employee
-$703,325
Market Cap
1.47B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
OCUL News
- 2 days ago - Ocular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused Company - GlobeNewsWire
- 12 days ago - Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025 - GlobeNewsWire
- 6 weeks ago - Ocular Therapeutix™ to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Ocular Therapeutix™ to Participate in Two Investor Conferences in April - GlobeNewsWire
- 3 months ago - Ocular Therapeutix Axpaxli Advances In Phase 3 For Wet AMD, Analyst Forecasts Huge Upside - Benzinga
- 4 months ago - Ocular Therapeutix: Axpaxli's Dual Trial Strategy And Blockbuster Potential - Seeking Alpha
- 4 months ago - Ocular Therapeutix, Inc. (OCUL) Q4 2024 Earnings Call Transcript - Seeking Alpha